Comments
Shares of AstraZeneca Pharma India Ltd today fell as much as 5.7 per cent, after gaining 26.7 per cent in the last three sessions till Thursday.
Investors’ outpoint gains were due to increasing focus of the parent in listed unit vs 100 per cent unlisted subsidiary.
Recent launches and distribution deals have happened via AstraZeneca’s listed unit only.
AstraZeneca had launched a drug diabetes treatment on Thursday. The company has entered into a distribution deal with Sun Pharmaceutical Industries and Dr. Reddy’s Labs.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.